Clinical trial

MAD Phase I Study to Investigate Contraloid Acetate

NCT03955380

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-12-12

PhasePHASE1

Study timeline

Study start (actual)2018-12-12Date precision: day

Registry last updated2019-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Dementiaunresolved

Alzheimer Diseaseunresolved

Interventions

Sponsors & collaborators

Prof. Dr. Dieter Willboldlead sponsor

Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germanycollaborator

Medical University of Viennacollaborator

NeuroScios, Austriacollaborator

Nuvisan, Germanycollaborator

Fundación Teófilo Hernando, Spaincollaborator

Alzheimer's Associationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03955380 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.